References
- Dunn M, Alexander J, de Silva R, et al. Antithrombotic therapy in atrial fibrillation. Chest 1989: 95(2 Suppl): 118–27S
- Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982: 306(17): 1018–22
- Stroke Prevention in Atrial Fibrillation Investigators. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990: 322(12): 863–8
- DeSilva RA, Graboys TB, Podrid PJ, et al. Cardioversion and defibrillation. Am Heart J 1980: 100(6 Pt 1): 881–95
- Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 1969: 23(2): 208–16
- Stein B, Halperin JL, Fuster V. Should patients with atrial fibrillation be anticoagulated prior to and chronically following cardioversion? In: Cheidin MD, ed. Dilemmas in clinical cardiology. Vol 21. Philadelphia: FA Davis, 1990: 231–49
- Cairns JA. Stroke prevention in atrial fibrillation trial. (Editorial) Circulation 1991: 84(2): 933–5
- Cairns JA, Connolly SJ. Nonrheumatic atrial fibrillation: risk of stroke and role of antithrombotic therapy. Circulation 1991: 84(2): 469–81
- Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987: 317(11): 669–74